|1.||Chen, Benjamin P C: 11 articles (04/2015 - 10/2006)|
|2.||Chen, David J: 10 articles (07/2015 - 09/2006)|
|3.||Zhou, Ping-Kun: 7 articles (08/2015 - 09/2005)|
|4.||Lin, Yu-Fen: 7 articles (04/2015 - 01/2011)|
|5.||Madhusudan, Srinivasan: 6 articles (01/2015 - 03/2013)|
|6.||Lee, Kyung-Jong: 5 articles (04/2015 - 10/2006)|
|7.||Arora, Arvind: 5 articles (01/2015 - 07/2014)|
|8.||Perry, Christina: 5 articles (01/2015 - 07/2014)|
|9.||Ellis, Ian O: 5 articles (01/2015 - 03/2013)|
|10.||Ball, Graham: 5 articles (01/2015 - 03/2013)|
11/06/2014 - "Animal models developed in the last years helped to better understand the involvement of individual PKCs in various cancer types and in the context of specific oncogenic alterations. "
01/01/2015 - "However, Atypical PKCs show contradictory regulation in different tissues or cancer cells. "
01/01/2014 - "It has been suggested that atypical PKCs contribute to cell proliferation and cancer progression. "
09/01/2013 - "Therapies developed targeting individual/multiple PKCs combined with conventional strategies offer promising future combating cancer. "
01/01/2013 - "Numerous anti-cancer activities have been attributed to I3A and ascribed to I3A's effects on PKCs. "
|2.||Colonic Neoplasms (Colon Cancer)
06/01/2012 - "These data indicate that small molecule inhibitors of DNA-PKcs dramatically enhance the efficacy of SN38 in colon cancer cell lines."
04/01/2014 - "Taken together, these results demonstrate a role for both AKT1 and AKT2 in radiotherapy response in colon cancer cells involving DNA repair capacity through the nonhomologous end joining pathway, thus suggesting that AKT in combination with DNA-PKcs inhibition may be used for radiotherapy sensitizing strategies in colon cancer. "
01/01/2011 - "This study showed the positive relationship between c-Myc expression in highly metastatic human prostate and colon cancer cells and susceptibility to TRAIL-induced apoptosis and therefore indicated that TRAIL might be used as an effective therapeutic modality for advanced metastatic cancers overexpressing c-Myc and combination of TRAIL therapy with agent that inhibits the DNA-PKcs/Akt signaling pathway might be clinically useful for the treatment of relatively TRAIL-insensitive human cancers."
06/01/2012 - "Irinotecan and DNA-PKcs inhibitors synergize in killing of colon cancer cells."
01/01/2011 - "Among these sites, phosphorylation of SMC1, NBS1, and Chk1 by DFO are mediated by ATR as it is greatly reduced in both ATR-deficient human fibroblasts and HCT116 human colon cancer cells in which ATR is heterozygously mutated, whereas these proteins are phosphorylated in cells deficient for ATM and DNA-PKcs. "
|3.||Glioblastoma (Glioblastoma Multiforme)
05/01/2015 - "Inhibition of DNA-PKcs may be a promising therapeutic approach to enhance radio-therapeutic efficacy for glioblastoma by hindering its angiogenesis."
05/01/2015 - "DNA-PKcs deficiency inhibits glioblastoma cell-derived angiogenesis after ionizing radiation."
01/01/2013 - "However, it is not clear whether VCP is involved in DNA-PKcs (DNA-PK catalytic subunit) degradation or whether it regulates the radiosensitivity of glioblastoma. "
07/01/2011 - "Members of the protein kinase D (PKD) family, which consists of PKD1, -2 and, -3, are prominent downstream targets of PKCs and could play a major role in glioblastoma growth. "
12/10/2007 - "Specifically, we address the role of DNA-PKcs and the novel potential end-joining factor KUB3 in maintaining the radioresistant phenotype, the interrelationship between genetic lesions and repair mechanisms, and new perspectives that emerge from the identification of glioblastoma stem cells."
|4.||Immune System Diseases (Immune Disorders)
12/15/2003 - "The importance of PKCs in cellular immune responses suggests that improved understanding of the molecular events that govern their actions could point to new avenues for development of treatments for immune disorders."
08/01/2014 - "More-recent studies have revealed that PKCs also have crucial roles in the pathogenesis of human immune disorders. "
01/01/2012 - "Protein kinase C θ (PKCθ) is a member of the PKCs family highly expressed in both immune cells and skeletal muscle; given its crucial role in adaptive, but also innate, immunity, it is being proposed as a valuable pharmacological target for immune disorders. "
01/01/2011 - "Inhibiting spinal PKMζ, but not full-length PKCs, also reversed mechanical hypersensitivity in the rat hind paw induced by spinal stimulation with intrathecal dihydroxyphenylglycine. "
10/15/2015 - "Loss of the DNA-binding component, Ku80, caused hypersensitivity to VE-821, but loss of its partner catalytic subunit, DNA-PKcs, did not. "
12/01/2012 - "We demonstrated that BTW3 exposure led to hypersensitivity to IR in DNA-PKcs-proficient cells but not in DNA-PKcs-deficient cells. "
12/01/2012 - "Inhibition of DNA-PKcs results in hypersensitivity to ionizing radiation (IR); therefore, this approach has been explored to develop molecular targeted radiosensitizers. "
01/01/2013 - "Taken together, these results demonstrate for the first time that cys-LT signaling downstream of CysLT1R in MCs is differentially regulated by two distinct PKCs which modulate inflammatory signals that have significant pathobiologic implications in allergic reactions and asthma pathology. "
|1.||DNA (Deoxyribonucleic Acid)
|2.||DNA-Activated Protein Kinase
|4.||Protein Isoforms (Isoforms)
|8.||Protein Kinases (Protein Kinase)
|9.||Proteins (Proteins, Gene)
|10.||1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)
|1.||Drug Therapy (Chemotherapy)
|4.||Heterologous Transplantation (Xenotransplantation)